Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome.
7 publications have been identified in PubMed for Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome. Research spans Case Report / Case Series (43%), Epidemiology / Natural History (29%), and Other (14%).
Blandon V (2025). [PMID: 40621364](https://pubmed.ncbi.nlm.nih.gov/40621364/). *Cureus*. [Case Report / Case Series]
Wankhade BS (2025). [PMID: 40237533](https://pubmed.ncbi.nlm.nih.gov/40237533/). *Anaesthesiol Intensive Ther*. [Other]
Zhou X (2025). [PMID: 40809354](https://pubmed.ncbi.nlm.nih.gov/40809354/). *Clin Cosmet Investig Dermatol*. [Case Report / Case Series]
Ma SH (2025). [PMID: 40238828](https://pubmed.ncbi.nlm.nih.gov/40238828/). *Clin Exp Dermatol*. [Epidemiology / Natural History]
Wells DA (2025). [PMID: 41417872](https://pubmed.ncbi.nlm.nih.gov/41417872/). *J Oncol Pharm Pract*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome
Lu H (2025). [PMID: 41366987](https://pubmed.ncbi.nlm.nih.gov/41366987/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Glahn JZ (2024). [PMID: 39127578](https://pubmed.ncbi.nlm.nih.gov/39127578/). *Burns*. [Epidemiology / Natural History]
AI-curated news mentioning Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome
Updated May 27, 2026
A 10-year retrospective analysis at Chelsea and Westminster Hospital highlights ocular involvement in toxic epidermal necrolysis syndrome. The study reviews current literature, providing insights into the complications associated with this severe skin condition.